SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33460347.
- Also identified by DOI 10.7326/M21-0111 and PMC identifier 7839932.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As COVID vaccines roll out, internists and other health care providers are being turned to as trusted sources of information for patients and communities. Here, experts from NIAID outline the current state of knowledge regarding such vaccines. They contrast vaccine platforms, summarize clinical trial data regarding efficacy and safety, and comment on key questions including the ability of current vaccines to protect against infection and to decrease the prevalence of virus in the community.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- Pneumonia, Viral
- Vaccines, Synthetic